When I first got into PAA, I always thought there was zero chance of it becoming worthless because Epichem was a nice back up, actually making money.
Now? After years of baloney, remarkable results being quietly forgotten and neglected, and Epichem being tossed aside like a useless steel bucket with plastic pipes hanging off it that has drained all SH confidence? I can actually see this sick puppy going to zero.
It’s actually a lot easier to imagine that scenario than any other.
Ann: Appendix 4C and Quarterly Update, page-27
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $210.6K | 1.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 274938 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 15000 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |